To evaluate ROS generation, labeling with 10 μM dihydroethidium (

To evaluate ROS generation, labeling with 10 μM dihydroethidium (DHE) (Molecular Probes) for 30 min at 28°C was performed, using 22 μM antimycin A (AA) (Sigma-Aldrich) as the positive control. The samples were analyzed in a FACSCalibur

flow cytometer (Becton Dickinson, CA, USA) equipped with the Cell Quest software (Joseph Trotter, Scripps Research Institute, La Jolla, USA). A total of 10,000 events were acquired in the region previously established as that of the parasites. Statistical analysis The comparison between control and treated groups was performed using the Mann–Whitney test. Differences with p ≤ 0.05 were considered statistically significant. Acknowledgments Funding was provided by Fundação de Amparo à Pesquisa do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento

Científico e Tecnológico this website (CNPq), Fundação Oswaldo Cruz (FIOCRUZ) and Spanish MICINN (Project SAF 2009–10399, to MTM). References 1. Rocha MO, Teixeira MM, Ribeiro AL: An update on the management of Chagas’ cardiomyopathy. HTS assay Exp Rev Anti-Infective Ther 2007, 5:727–743.CrossRef 2. Rassi A Jr, Rassi A, Marin-Neto JA: Chagas’ disease. Lancet 2010, 375:1388–1402.PubMedCrossRef 3. Schmunis GA, Yadon ZE: Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 2010, 115:14–21.PubMedCrossRef 4. Soeiro MNC, De Castro SL: Screening of potential anti- Trypanosoma cruzi candidates: In vitro and in vivo studies. Open Med Chem J 2011, 5:21–30.CrossRef 5. O’Brien PJ: Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 1991, 80:1–41.PubMedCrossRef 6. Bastien JW: Pharmacopeia of qollahuaya Andeans. J Ethnopharmacol 1983, 8:97–111.PubMedCrossRef 7. Arenas P: Medicine and magic among the maka Indians of the Paraguayan Chaco. J Ethnopharmacol 1987, 21:279–295.PubMedCrossRef 8. Constantino L, Barlocco D: Privileged structures as leads in medicinal chemistry. Curr Med Chem 2006, 13:65–85.CrossRef 9. Pinto AV, Resminostat De Castro SL: The trypanocidal activity of naphthoquinones: a review. Molecules

2009, 14:4570–4590.PubMedCrossRef 10. Salas CO, Faúndez M, Morello A, Maya JD, Tapia RA: Natural and synthetic naphthoquinones active against Trypanosoma cruzi : an initial step towards new drugs for Chagas’ disease. Curr Med Chem 2011, 18:144–161.PubMedCrossRef 11. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ: Role of quinones in toxicology. Chem Res Toxicol 2000, 13:135–160.PubMedCrossRef 12. Babula P, Adam V, Kizek R, Sladky Z, Havel L: Naphthoquinones as allelochemical triggers of programmed cell death. Environm Exp Bot 2009, 65:330–337.CrossRef 13. Esnault S, Braun RK, Shen ZJ, Xiang Z, Heninger E, Love RB, Sandor M, Malter JS: Pin1 modulates the type 1 immune response. PLoS One 2007, 2:e226.PubMedCrossRef 14.

Comments are closed.